Mc Graw-Hill. Les bases pharmacologiques de l'utilisation des médicaments 9 ème Edition. International Ltd, pp.881-900, 1998. ,
Pharmacologie fondamentale et clinique 7 ème Edition, pp.583-596, 2000. ,
Pharmacologie des concepts fondamentaux aux applications thérapeutiques. Edition Frisson-Roche, pp.555-565, 1998. ,
Efficacité et efficience des hypolipémiants : une analyse centrée sur les statines. Evaluation des technologies de santé analyse médico-économique, 2010. ,
Epidemiology according to the European and French scales of myocardial infarction. Data of the MONICA project, Arch Mal Coeur Vaiss, vol.89, issue.3, pp.13-21, 1996. ,
Frequency of Family History of Acute Myocardial Infarction in Patients With Acute Myocardial Infarction, Argentine FRICAS (Factores de Riesgo Coronario en America del Sur) Investigators, pp.122-129, 1997. ,
DOI : 10.1016/S0002-9149(97)00304-4
Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study, European Heart Journal, vol.23, issue.21, pp.1655-63, 2002. ,
DOI : 10.1053/euhj.2002.3235
How soon after quitting smoking does risk of heart attack decline?, Journal of Clinical Epidemiology, vol.44, issue.11, pp.1247-53, 1991. ,
DOI : 10.1016/0895-4356(91)90157-5
Rapid reduction in coronary risk for those who quit cigarette smoking, Australian and New Zealand Journal of Public Health, vol.97, issue.1, pp.787-91, 1998. ,
DOI : 10.1111/j.1467-842X.1998.tb01494.x
Accréditation et d'Évaluation en Santé Prise en charge des patients adultes atteints d'hypertension artérielle essentielle. Recommandations cliniques et données économiques, 2000. ,
Epidemiology of cardio-vascular complications of diabetes, Diabetes Metab, vol.25, issue.3, pp.12-20, 1999. ,
Epidemiology of macrovascular disease in diabetes, Diabetes Rev, vol.5, pp.294-315, 1997. ,
Diabetes and cardiovascular risk factors: the Framingham study, Circulation, vol.59, issue.1, pp.8-13, 1979. ,
DOI : 10.1161/01.CIR.59.1.8
Mortality in Adults With and Without Diabetes in a National Cohort of the U.S. Population, 1971-1993, Diabetes Care, vol.21, issue.7, pp.1138-1183, 1998. ,
DOI : 10.2337/diacare.21.7.1138
Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes, Diabetes Care, vol.18, issue.2, pp.258-68, 1995. ,
DOI : 10.2337/diacare.18.2.258
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study, BMJ, vol.313, issue.7060, pp.779-84, 1996. ,
DOI : 10.1136/bmj.313.7060.779
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23), BMJ, vol.316, issue.7134, pp.823-831, 1998. ,
DOI : 10.1136/bmj.316.7134.823
Coronary Heart Disease Mortality Is Actually Low in Diabetic Japanese by Direct Comparison With the Joslin Cohort, Diabetes Care, vol.17, issue.9, pp.1062-1065, 1994. ,
DOI : 10.2337/diacare.17.9.1062
Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis, Diabetes Care, vol.21, issue.11, pp.1861-1870, 1998. ,
DOI : 10.2337/diacare.21.11.1861
The Mystery of Diabetes and Atherosclerosis: Time for a New Plot, Diabetes, vol.46, issue.3, pp.327-361, 1997. ,
DOI : 10.2337/diab.46.3.327
Atherosclerosis and cardio-vascular complications of diabetes], Ann Endocrinol (Paris), vol.57, pp.161-166, 1996. ,
Endothelium in insulin resistance and diabetes, Diabetes Rev, vol.5, pp.343-53, 1997. ,
Arterial thrombosis and atherosclerosis in diabetes, Diabetes Rev, vol.5, pp.316-347, 1997. ,
Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study, Diabetologia, vol.32, pp.300-304, 1989. ,
Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes, Circulation, vol.88, issue.4, pp.1421-1451, 1993. ,
DOI : 10.1161/01.CIR.88.4.1421
Obesity as an Independent Risk Factor for Cardiovascular Disease, Survey of Anesthesiology, vol.28, issue.1, pp.968-77, 1983. ,
DOI : 10.1097/00132586-198402000-00001
Variability of Body Weight and Health Outcomes in the Framingham Population, New England Journal of Medicine, vol.324, issue.26, pp.1839-1883, 1991. ,
DOI : 10.1056/NEJM199106273242602
Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality A prospective population study, European Heart Journal, vol.20, issue.4, pp.269-77, 1999. ,
DOI : 10.1053/euhj.1998.1235
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, The Lancet, vol.364, issue.9438, pp.937-52, 2004. ,
DOI : 10.1016/S0140-6736(04)17018-9
Selective screening for dyslipidemia in a Canadian population, Journal of Clinical Epidemiology, vol.49, issue.2, pp.217-239, 1996. ,
DOI : 10.1016/0895-4356(95)00063-1
Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work?, JAMA: The Journal of the American Medical Association, vol.274, issue.10, pp.801-807, 1995. ,
DOI : 10.1001/jama.274.10.801
Identifying Adults at Low Risk for Significant Hyperlipidemia A Validated Clinical Index, Journal of Clinical Epidemiology, vol.52, issue.1, pp.49-55, 1999. ,
DOI : 10.1016/S0895-4356(98)00139-5
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913., BMJ, vol.288, issue.6428, pp.1401-1405, 1984. ,
DOI : 10.1136/bmj.288.6428.1401
Body weight and mortality. A 27-year follow-up of middle-aged men, JAMA: The Journal of the American Medical Association, vol.270, issue.23, pp.2823-2831, 1993. ,
DOI : 10.1001/jama.270.23.2823
Relation of Serum Uric Acid to Mortality and Ischemic Heart Disease, American Journal of Epidemiology, vol.141, issue.7, pp.637-681, 1995. ,
DOI : 10.1093/oxfordjournals.aje.a117479
A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians, JAMA: The Journal of the American Medical Association, vol.268, issue.7, pp.877-81, 1992. ,
DOI : 10.1001/jama.268.7.877
Serum Total Homocysteine and Coronary Heart Disease, International Journal of Epidemiology, vol.24, issue.4, pp.704-713, 1995. ,
DOI : 10.1093/ije/24.4.704
Identifying and managing patients with hyperlipidemia, Am J Manag Care, vol.3, pp.1211-1220, 1997. ,
Fibrinogen as a Cardiovascular Risk Factor, Annals of Internal Medicine, vol.118, issue.12, pp.956-63, 1993. ,
DOI : 10.7326/0003-4819-118-12-199306150-00008
Alcohol Consumption and Coronary Heart Disease Morbidity and Mortality, American Journal of Epidemiology, vol.146, issue.6, pp.495-501, 1997. ,
DOI : 10.1093/oxfordjournals.aje.a009303
A longitudinal analysis of the impact of dietary intake and physical activity on weight change in adults, Am J Clin Nutr, vol.55, pp.818-840, 1992. ,
Clinical Pharmacokinetics of Fluvastatin, Clinical Pharmacokinetics, vol.67, issue.2, pp.263-81, 2001. ,
DOI : 10.2165/00003088-200140040-00003
Safety of pravastatin in long term clinical trials conducted in united states, J Drug Dev, vol.3, pp.275-280, 1990. ,
Pravastatin a new drug for the treatment of hypercholesterolemia, Clin Pharm, vol.11, issue.8, pp.677-689, 1992. ,
Fluvastatin, Drugs, vol.51, issue.3, pp.433-59, 1996. ,
DOI : 10.2165/00003495-199651030-00011
Atorvastatin in the Treatment of Primary Hypercholesterolemia and Mixed Dyslipidemias, Annals of Pharmacotherapy, vol.265, issue.4, pp.1030-1073, 1998. ,
DOI : 10.1161/01.CIR.91.10.2528
A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia, The American Journal of Cardiology, vol.80, issue.1, pp.39-44, 1997. ,
DOI : 10.1016/S0002-9149(97)00280-4
Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin, British Journal of Clinical Pharmacology, vol.63, issue.1, pp.49-53, 1998. ,
DOI : 10.1046/j.1365-2125.1998.00034.x
Thrombotic Thrombocytopenic Purpura: Yesterday, Today, Tomorrow, Therapeutic Apheresis and Dialysis, vol.70, issue.2, pp.80-86, 2004. ,
DOI : 10.1182/blood-2003-01-0193
Thrombotic thrombocytopenic purpura and simvastatin, Lancet, vol.352, pp.1284-1289, 1998. ,
Simvastatin-induced thrombocytopaenia: a further case and a brief on its clinical relevance, Annals of Hematology, vol.97, issue.9, pp.773-777, 2008. ,
DOI : 10.1007/s00277-008-0480-1
Atorvastatin-induced severe thrombocytopenia, The Lancet, vol.352, issue.9136, p.1284, 1998. ,
DOI : 10.1016/S0140-6736(05)70491-8
Rosuvastatin-Induced Thrombocytopenia, Southern Medical Journal, vol.103, issue.7, pp.676-684, 2010. ,
DOI : 10.1097/SMJ.0b013e3181e170f5
Simvastatin and alopecia, Aust Adverse drug reacr Bull, vol.12, p.7, 1993. ,
Alopecia associated with atorvastatin, The American Journal of Medicine, vol.113, issue.2, p.171, 2002. ,
DOI : 10.1016/S0002-9343(02)01135-X
Proteinuria as complication of simvastatin treatment, The Lancet, vol.336, issue.8728, p.1453, 1990. ,
DOI : 10.1016/0140-6736(90)93164-K
Atorvastatin-Induced Hemorrhagic Cystitis: A Case Report, Urology, vol.73, issue.3, pp.681-686, 2009. ,
DOI : 10.1016/j.urology.2008.03.027
Depressive symptoms in hypercholesterolaemic patients treated with pravastatin, The Lancet, vol.340, issue.8824, p.910, 1992. ,
DOI : 10.1016/0140-6736(92)93318-H
Depressive symptoms and cholesterol-lowering drugs, The Lancet, vol.341, issue.8837, p.114, 1993. ,
DOI : 10.1016/0140-6736(93)92591-G
Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration, BMJ, vol.313, issue.7049, pp.75-83, 1996. ,
DOI : 10.1136/bmj.313.7049.75
Long-term Assessment of Psychological Well-being in a Randomized Placebo-Controlled Trial of Cholesterol Reduction With Pravastatin, Archives of Internal Medicine, vol.160, issue.20, pp.3144-52, 2000. ,
DOI : 10.1001/archinte.160.20.3144
Behavioral changes with paranoia in an elderly woman taking atorvastatin, The American Journal of Geriatric Pharmacotherapy, vol.6, issue.1, pp.28-32, 2008. ,
DOI : 10.1016/j.amjopharm.2008.03.001
Short-Term Memory Loss Associated with Rosuvastatin, Pharmacotherapy, vol.57, issue.7, pp.1190-1192, 2006. ,
DOI : 10.1592/phco.2005.25.7.990
Cognitive Impairment Associated with Atorvastatin and Simvastatin, Pharmacotherapy, vol.34, issue.12, pp.1663-1670, 2003. ,
DOI : 10.1001/archinte.160.20.3144
Association of HMG-CoA Reductase Inhibitors with Neuropathy, Annals of Pharmacotherapy, vol.344, issue.2, pp.274-281, 2003. ,
DOI : 10.1038/clpt.1981.154
Paresthesia and neuropathy with hypolipidaemia agents, Aust Adverse Drug Reac Bull, vol.12, p.6, 1993. ,
Peripheral neuropathy associated with simvastatin., Journal of Neurology, Neurosurgery & Psychiatry, vol.58, issue.5, pp.625-633, 1995. ,
DOI : 10.1136/jnnp.58.5.625
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1073498
Statins and peripheral neuropathy, European Journal of Clinical Pharmacology, vol.54, issue.11, pp.835-843, 1999. ,
DOI : 10.1007/s002280050562
HMG-CoA Reductase Inhibitor Therapy and Peripheral Neuropathy, Annals of Internal Medicine, vol.120, issue.11, p.970, 1994. ,
DOI : 10.7326/0003-4819-120-11-199406010-00013
Multiple mononeuropathy associated to treatment with pravastatin Partina Galandú s/n, E-03570 Villajoyosa, Rev Neurol, vol.43, issue.11, pp.659-61, 2006. ,
Simvastatin-induced mononeuropathy multiplex: case report, Arquivos de Neuro-Psiquiatria, vol.62, issue.2b, pp.540-542, 2004. ,
DOI : 10.1590/S0004-282X2004000300031
URL : http://doi.org/10.1590/s0004-282x2004000300031
Two Cases of Statin-Induced Rhabdomyolysis Associated with Mononeuropathy, Clinical Drug Investigation, vol.166, issue.5, pp.347-50, 2010. ,
DOI : 10.2165/11535470-000000000-00000
Neuromuscular Complications of Statins, Physical Medicine and Rehabilitation Clinics of North America, vol.19, issue.1, pp.47-59, 2008. ,
DOI : 10.1016/j.pmr.2007.10.002
Drug points: Simvastatin and impotence, BMJ, vol.315, issue.7099, p.31, 1997. ,
DOI : 10.1136/bmj.315.7099.31a
Simvastatin seems unlikely to cause impotence, BMJ, vol.318, issue.7177, p.192, 1999. ,
DOI : 10.1136/bmj.318.7177.192a
Do lipid-lowering drugs cause erectile dysfunction? A systematic review, Family Practice, vol.19, issue.1, pp.95-103, 2002. ,
DOI : 10.1093/fampra/19.1.95
Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia., BMJ, vol.301, issue.6753, p.669, 1990. ,
DOI : 10.1136/bmj.301.6753.669-a
Sleep Disturbance and HMG CoA Reductase Inhibitors, JAMA: The Journal of the American Medical Association, vol.264, issue.9, p.1105, 1990. ,
DOI : 10.1001/jama.1990.03450090041020
The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolemia, Br J Clin Pharmacol, vol.35, pp.284-293, 1993. ,
Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study, British Journal of Clinical Pharmacology, vol.151, issue.1, pp.483-90, 1996. ,
DOI : 10.1111/j.1365-2125.1996.tb00012.x
A case of acute cholestatic hepatitis associated with fluvastatin sodium, J Med Soc Toho, vol.48, pp.153-161, 2001. ,
Cholestasis associated with the use of pravastatin sodium, Med J Aust, vol.176, issue.11, p.561, 2002. ,
Liver toxicity of rosuvastatin therapy. Department of Internal Medicine, World J Gastroenterol Feb, vol.2813, issue.8, pp.1286-1294, 2007. ,
Reversible Acute Hepatitis Induced by Rosuvastatin, Southern Medical Journal, vol.101, issue.7, p.768, 2008. ,
DOI : 10.1097/SMJ.0b013e3181778d75
Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report, Acta Gastroenterol Belg, vol.71, issue.3, pp.318-338, 2008. ,
Hepatitis colest??sica aguda tras la reintroducci??n de atorvastatina, Servicio de Aparato Digestivo, pp.21-25, 2006. ,
DOI : 10.1157/13083248
Acute cholestatic hepatitis after reinitiating treatment with atorvastatin, Journal of Hepatology, vol.37, issue.1, pp.165-171, 2002. ,
DOI : 10.1016/S0168-8278(02)00092-2
Statins and Pancreatitis, Drug Safety, vol.13, issue.1, pp.1123-1155, 2006. ,
DOI : 10.2165/00002018-200629120-00004
A case of simvastatin-associated pancreatitis and review of statinassociated pancreatitis Department of Pharmacy: Clinical and Administrative Sciences, pp.414-436, 2006. ,
Pancréatite aigue à la simvastatine: 2 cas, Gastroenterol Clin Biol, vol.15, issue.12, p.986, 1991. ,
La simvastatine: une nouvelle molécule responsable de pancréatite aigue ?, Gastroenterol Clin Bio, vol.15, issue.1, pp.93-97, 1991. ,
Spontaneous reports on drug induced pancreatitisin denmark from 1968 to 1999, Eur J Clin Pharmacol, vol.57, pp.6-7, 2001. ,
Acute pancreatitis due to simvastatin therapy: increased severity after rechallenge, Digestive and Liver Disease, vol.36, issue.9, pp.639-679, 2004. ,
DOI : 10.1016/j.dld.2004.05.002
Acute pancreatitis induced by fluvastatin therapy. Department of Medicine, J Clin Gastroenterol, 2002. ,
DOI : 10.1097/00004836-200211000-00010
Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? Department of Internal Medicine, Unity Health System, pp.502-506, 2004. ,
Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review, Journal of the European Academy of Dermatology and Venereology, vol.142, issue.1, pp.17-24, 2007. ,
DOI : 10.1038/nrd1471
Atorvastatin-induced reversible positive antinuclear antibodies, The American Journal of Medicine, vol.112, issue.4, pp.329-359, 2002. ,
DOI : 10.1016/S0002-9343(01)01102-0
Syndrome d???hypersensibilit?? m??dicamenteuse induit par l???atorvastatine, Annales de Dermatologie et de V??n??r??ologie, vol.136, issue.1, pp.50-53, 2009. ,
DOI : 10.1016/j.annder.2008.07.063
Lupus-Like Syndrome Associated with Statin Therapy, Dermatology, vol.208, issue.3, pp.276-283, 2004. ,
DOI : 10.1159/000077320
Simvastatin-Induced Lupus Erythematosus, Southern Medical Journal, vol.91, issue.9, pp.873-877, 1998. ,
DOI : 10.1097/00007611-199809000-00016
Disorder resembling Guillain-Barr?? syndrome on initiation of statin therapy, Muscle & Nerve, vol.91, issue.5, pp.663-669, 2004. ,
DOI : 10.1002/mus.20112
Fatal lupus-like syndrome and ARDS induced by fluvastatin, The Lancet, vol.352, issue.9122, p.114, 1998. ,
DOI : 10.1016/S0140-6736(98)85019-8
Statin-induced Ro/SSa-positive subacute cutaneous lupus erythematosus, Clinical and Experimental Dermatology, vol.43, issue.5, pp.589-91, 2007. ,
DOI : 10.1159/000077320
Interstitial lung disease with pleural effusion caused by Simvastin, Journal of Internal Medicine, vol.239, issue.4, pp.361-364, 1996. ,
DOI : 10.1046/j.1365-2796.1996.411762000.x
Hypersensitivity pneumonitis in a patient taking pravastatin. Département de Médecine interne et Pneumologie, Rev Mal Respir, vol.18, issue.4, pp.426-434, 2001. ,
Bilateral pleural effusions associated with pravastatin sodium treatment, European Respiratory Journal, vol.30, issue.5, p.1022, 2007. ,
DOI : 10.1183/09031936.00087007
Gynecomastia due to pravastatin, Presse Med, p.787, 1999. ,
Golf-inhibiting gynecomastia associated with atorvastatin therapy. Moses Cone Health System, pp.1165-1173, 2006. ,
DOI : 10.1592/phco.26.8.1165
Gynecomastia Possibly Induced by Rosuvastatin, Pharmacotherapy, vol.160, issue.4, pp.549-51, 2008. ,
DOI : 10.1038/clpt.1981.154
Chronic urticaria to atorvastatin, Allergy, vol.57, issue.4, p.366, 2002. ,
DOI : 10.1067/mjd.2001.113462
Linear IgA bullous dermatosis induced by atorvastatin, Journal of the American Academy of Dermatology, vol.44, issue.4, pp.689-92, 2001. ,
DOI : 10.1067/mjd.2001.113462
Dermatographism: An adverse effect of atorvastatin, Am Board Fam Pract, vol.14, issue.2, pp.148-51, 2001. ,
Pravastatin-induced lichenoid drug eruption ,
Cheilitis due to treatment with simvastatin, Dermatopathology Laboratory, vol.62, issue.4, pp.197-205, 1998. ,
Atrial fibrillation induced by simvastatin treatment in a 61-year-old man Heart Vessels, pp.157-166, 2003. ,
Simvastatin-induced lactic acidosis: A rare adverse reaction?, Clinical Pharmacology & Therapeutics, vol.72, issue.4, pp.461-465, 2002. ,
DOI : 10.1067/mcp.2002.127943
Adverse Effects of Statins - Mechanisms and Consequences, Current Drug Safety, vol.4, issue.3, pp.209-237, 2009. ,
DOI : 10.2174/157488609789006949
New insights into mechanisms of statin-associated myotoxicity ,
Clinical characterization and molecular mechanisms of statin myopathy, Expert Review of Cardiovascular Therapy, vol.6, issue.7, pp.955-69, 2008. ,
DOI : 10.1586/14779072.6.7.955
Statin-induced muscular symptoms: a report of 3 cases. Department of Trauma and Orthopaedics, Acta Orthop Belg, vol.74, issue.4, pp.569-72, 2008. ,
Statin-associated focal myositis, International Journal of Cardiology, vol.133, issue.1, pp.33-37, 2009. ,
DOI : 10.1016/j.ijcard.2007.08.109
Pravastatin-associated inflammatory myopathy, N Engl J Med, vol.327, pp.649-50, 1992. ,
Atorvastatin-induced dermatomyositis, The American Journal of Medicine, vol.110, issue.8, pp.670-671, 2001. ,
DOI : 10.1016/S0002-9343(01)00711-2
Atorvastatin, Drugs, vol.53, issue.5, pp.828-875, 1997. ,
DOI : 10.2165/00003495-199753050-00011
Statin-Associated Myasthenia Gravis, Midwest Eye Institute, pp.82-87, 2006. ,
DOI : 10.1097/01.md.0000209337.59874.aa
Fatal and Widespread Skeletal Myopathy Confirmed Morphologically Years After Initiation of Simvastatin Therapy, The American Journal of Cardiology, vol.99, issue.8, pp.1171-1177, 2007. ,
DOI : 10.1016/j.amjcard.2006.11.071
Rapid Onset of Muscle Weakness (Rhabdomyolysis) Associated With the Combined Use of Simvastatin and Colchicine, JCR: Journal of Clinical Rheumatology, vol.13, issue.5, pp.266-274, 2007. ,
DOI : 10.1097/RHU.0b013e318156d977
Possible colchicine rhabdomyolysis in a fluvastatintreated patient Ann Pharmacother, pp.7-81368, 2005. ,
Simvastatin-Associated Rhabdomyolysis After Coadministration of Macrolide Antibiotics in Two Patients, Pharmacotherapy, vol.63, issue.4, pp.603-610, 2007. ,
DOI : 10.1185/030079905X65466
Rhabdomyolysis Associated with Concomitant Use of Atorvastatin and Cyclosporine, Annals of Pharmacotherapy, vol.57, issue.11, pp.1176-1185, 1999. ,
DOI : 10.1056/NEJM199509073331003
Rosuvastatin-induced rhabdomyolysis probably via CYP2C9 saturation. Department of Experimental and Clinical Medicine, Faculty of Medicine and Surgery, luca_gallelli@gmail.com. Drug Metabol Drug Interact, vol.24, issue.1, pp.83-90, 2009. ,
Rhabdomyolysis in an HIV-Infected Patient on Anti-Retroviral Therapy Precipitated by High-Dose Pravastatin, Current Drug Safety, vol.4, issue.2, pp.121-123, 2009. ,
DOI : 10.2174/157488609788173080
Rabdomi??lise devido ao uso de estatina em altas doses: relato de caso, Arquivos Brasileiros de Endocrinologia & Metabologia, vol.49, issue.4, pp.604-613, 2005. ,
DOI : 10.1590/S0004-27302005000400021
Rhabdomyolysis as a side effect of simvastatin treatment0, Iskra B, Zivko M, Kes P. Interni odjel Acta Med Croatica, vol.59, issue.4, pp.325-333, 2005. ,
Two Cases of Statin-Induced Rhabdomyolysis Associated with Mononeuropathy, Clinical Drug Investigation, vol.166, issue.5, pp.347-50, 2010. ,
DOI : 10.2165/11535470-000000000-00000
Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin, Clinical Therapeutics, vol.29, issue.1, pp.172-178, 2007. ,
DOI : 10.1016/j.clinthera.2007.01.017
Rhabdomyolysis after treatment with atorvastatin detected by bone scintigraphy, Hospital Clínic, vol.25, issue.6, p.393, 2006. ,
Statin-induced rhabdomyolysis and renal failure: also with fluvastatine Servicio de Medicina Interna, An Med Interna, vol.21, issue.5, pp.235-242, 2004. ,
Rhabdomyolysis induced by a single dose of a statin. Medical Directorate, Chesterfield and North Derbyshire Royal Hospital NHS Calow, p.3, 2004. ,
Stockley's Drug interaction. 18 Ed, PhP, vol.12, pp.449-52, 2008. ,
Effect of Rosuvastatin on Warfarin Pharmacodynamics and Pharmacokinetics, The Journal of Clinical Pharmacology, vol.58, issue.8, pp.927-961, 2005. ,
DOI : 10.1177/0091270005278224
UK Summary of product characteristics Atorvastatin, 2006. ,
Safety and Tolerability of Fluvastatin With Concomitant Use of Antihypertensive Agents: An Analysis of a Clinical Trial Database, American Journal of Hypertension, vol.6, issue.11 Pt 2, pp.346-352, 1993. ,
DOI : 10.1093/ajh/6.11.346S
The interaction of diltiazem with lovastatin and pravastatin*, Clinical Pharmacology & Therapeutics, vol.318, issue.4, pp.369-77, 1998. ,
DOI : 10.1016/S0009-9236(98)90067-4
Stockley's Drug interaction. 18 Ed, PhP, vol.30, p.1096, 2008. ,
Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin, The American Journal of Cardiology, vol.84, issue.7, pp.811-826, 1999. ,
DOI : 10.1016/S0002-9149(99)00442-7
Stockley's Drug interaction. 18 Ed, PhP, vol.30, p.1092, 2008. ,
Stockley's Drug interaction. 18 Ed, PhP, vol.30, p.1099, 2008. ,
Colchicine-Induced Acute Myopathy in a Patient With Concomitant Use of Simvastatin, Clinical Neuropharmacology, vol.25, issue.5, pp.226-234, 2002. ,
DOI : 10.1097/00002826-200209000-00008
Adverse Events With Concomitant Amiodarone and Statin Therapy, Preventive Cardiology, vol.8, issue.2, pp.95-102, 2005. ,
DOI : 10.1016/S0002-9343(01)00870-1
Stockley's Drug interaction. 18 Ed, PhP, vol.30, pp.1104-1109, 2008. ,
Stockley's Drug interaction. 18 Ed, PhP, vol.30, p.1095, 2008. ,
New insights into mechanisms of statin-associated myotoxicity, Current Opinion in Pharmacology, vol.8, issue.3, pp.333-338, 2008. ,
DOI : 10.1016/j.coph.2007.12.010